You just read:

Arena Reports Second Quarter Financial Results with Strong Liquidity Position, and Initiation of Etrasimod ELEVATE UC 52 and Olorinab CAPTIVATE Trials

News provided by

Arena Pharmaceuticals, Inc.

Aug 07, 2019, 16:01 ET